awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53342780-A5FE2F19-D8E7-4637-AB3F-783008DA3160
Q53342780-A5FE2F19-D8E7-4637-AB3F-783008DA3160
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53342780-A5FE2F19-D8E7-4637-AB3F-783008DA3160
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.
P2860
Q53342780-A5FE2F19-D8E7-4637-AB3F-783008DA3160
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53342780-A5FE2F19-D8E7-4637-AB3F-783008DA3160
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93b43d89439b14252bfcb8a83e85e94df36060e7
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti